Glance™ is a new AI platform that integrates biomedical databases and embraces cutting-edge deep learning models to unlock hidden clues under enormous data. Our platform simplifies complex networks of biomedical data around protein targets and drug candidates, such as biomedical literature, assays, chemical and gene profiles, and extracts the most relevant ones providing insights for target identification, and drug repurposing.
Skeleton™ provides a novel way to find and optimize the drug candidates for your protein targets. With the large in-house database of compound fragments annotated by our AI technologies, it discovers unidentified pharmaceutical functionings of candidates, and it also constructs the best combinations of the fragments that fit into the binding sites in the targets. Skeleton™ makes novel drug design and screening possible with unprecedented precision.
Changing the Game
We’re a young and talented group of entrepreneurs and engineers in pharmaceutics and machine learning fields with a groundbreaking idea designed to contribute towards a better tomorrow. We provide smart solutions for ongoing problems in biomedical academy and industry and pride ourselves on our unparalleled, dedicated service. At Bionsight, we believe that the right understanding and technological edge can lead companies towards a successful future.